BTA Current

Baar-Ebenhausen near Ingolstadt, [14/08/2024] - 

The DIAPOSIDEX study, a pioneering clinical investigation to improve diabetes treatment, is seeking participants for its current phase. This study aims to explore new therapeutic approaches and could bring breakthrough advances in the treatment of diabetes.

What is the DIAPOSIDEX study?

The DIAPOSIDEX study is an advanced research project focussing on the development and evaluation of new treatment strategies for diabetes. The study is being conducted by an interdisciplinary team of experts led by Prof. Siegfried Jedamzik, MD, and aims to test innovative therapeutic approaches that could revolutionise the management of diabetes. By participating in the study, patients have the opportunity to benefit from the latest medical findings and technologies.

Why is the study important?

Diabetes is a major challenge for patients and the healthcare system. Despite significant advances in treatment, the search for better, personalised treatment options remains crucial. The DIAPOSIDEX study provides an opportunity to evaluate innovative therapeutic approaches that may significantly improve treatment outcomes.

Advantages for participants:

- Access to the latest therapeutic approaches: Participants can test new and promising treatment options before they are generally available.

- Close medical care: Study participants will receive comprehensive care throughout the duration of the study, including regular check-ups and individual counselling.

- Contribution to medical research: Your participation helps to gain important insights that could improve the future treatment of diabetes.

Participation requirements:

The study is aimed at people who suffer from type 1 or type 2 diabetes. Interested parties can obtain detailed information on the conditions of participation on the website https://www.diaposidex.de and find out whether they are eligible for the study.

How can you take part?

Interested persons can register on the website https://www.diaposidex.de and receive all the necessary information. The dedicated DIAPOSIDEX study team is available to answer questions and guide participants through the enrolment process.

About DIAPOSIDEX:

DIAPOSIDEX is a leading research initiative specialising in the development of innovative therapies for diabetes. Through our dedicated research and advanced clinical trials, we are working to improve the quality of life of people with diabetes worldwide and open up new treatment options.

Notes for editors:

Participation in the study is free of charge.

Further information can be found on our website https://www.diaposidex.de/.

Contact:

GOIN e.V.

Oberer Grasweg 50

85055 Ingolstadt

Tel.: 0841 88668-0

Fax: 0841 88668-18

E-mail: info@go-in-ingolstadt.de

Homepage: www.goin.info

The innovative spasticity app, developed by Prof Dr Siegfried Jedamzik with the support of Dr Friedemann Müller, Head of Neurological Early Rehabilitation & Rehabilitation at the Schön Klinik Bad Aibling Harthausen, now offers an innovative solution for patients and their families who are confronted with the consequences of a stroke.

An impressive example of the benefits of the spasticity app is the story of Mrs M. Huber, whose grandfather recently suffered a stroke. ‘It was a scary and uncertain time for our family,’ she says, ’but with the discovery of the spasticity app, we felt better equipped to deal with the challenges that a stroke brings.’

The spasticity app was developed specifically to help patients who have had a stroke to recognise the development of spasticity at an early stage. Spasticity is an abnormal increase in muscle tension caused by damage to the central nervous system and often develops within the first 30 days after a stroke.

Thanks to the intuitive user interface and the integrated 10-question traffic light questionnaire, users can quickly and easily determine whether they are showing signs of spasticity. ‘The app gave us clear recommendations as to whether or not we should seek further medical advice,’ adds Ms Huber.

Another advantage of the app is the comprehensive information on the treatment of spasticity with botulinum toxin. This drug, derived from the bacterium Clostridium botulinum, has been proven to be an effective treatment for spasticity. The effect starts just a few days after the injection and usually lasts for three to four months.

‘We are really grateful for this app,’ says Mrs M. Huber. ‘It has not only helped us to orientate ourselves better during this difficult time, but also to offer my grandfather the best possible support.’

THEREFORE: Use the spasticity app and take your health into your own hands!

Dear sufferers and relatives, if you or a relative have recently suffered a stroke, you know how stressful the consequences can be. The Spastic App is here to support you! 

With this innovative application you can:

✔ Detect spasticity early: With a simple 10-question test, you can recognise signs of spasticity at an early stage and act accordingly.

✔ Medical expertise: Find out in detail about spasticity and its treatment, in particular about effective treatment with botulinum toxin.

✔ Clear recommendations for action: Based on your test results, the app gives you clear recommendations on whether or not you should seek further medical advice.

✔ Multilingual support: The app is available in 9 different languages, so you get the best information in your native language.

Promoting health and wellbeing after a stroke is of paramount importance. Let the Spastic app accompany you on this journey. Download the Spastic app now for free from the App Store or Google Play Store and see the benefits for yourself!

For more information and to download the Spastic app, visit the website

www.spastik-app.de

With the Corona pandemic, telemedicine has received a boost - also in Ingolstadt ...